Canada Stents Market Insight
Published: 18 May 2026 | Report Format: Electronic (PDF)
The Canada stents market size is growing at a 4.94% CAGR, driven by the rising cardiovascular diseases, aging population, and minimally invasive surgeries drive healthcare growth across Canada.
Canada Stents Market Insights Forecasts to 2035
- The Canada Stents Market Size Was Estimated at USD 1.178 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 4.94% from 2025 to 2035
- The Canada Stents Market Size is Expected to Reach USD 1.908 Million by 2035
Notable Insights for Canada Stents Market
- By type, coronary stents had a share of nearly 60-61% in the Canada stents market during 2025, driven by the growing incidence of coronary artery disease and the growing popularity of minimally invasive heart disease treatments.
- By material, metallic stents held a share of around 67-68% in 2025 due to their durability, efficacy, and extensive usage in interventional cardiology procedures in Canada.
- The Canadian government spent more than CAD 52.1 billion on provincial health care transfers during 2024-2025 for the modernization of hospitals, cardiovascular care facilities, and medical devices.
- Health Canada has continuously regulated cardiovascular implants and stent technology under the medical device licensing process.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Canada stents market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment Market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the Market.
Top Companies in Canada Stents Market
-
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
- B. Braun SE
- BIOTRONIK SE & Co. KG
- Terumo Corporation
- Cook Medical
- MicroPort Scientific Corporation
- Teleflex Incorporated
- Edwards Lifesciences Corporation
Recent Developments:
- In March 2024, Abbott advanced its XIENCE drug-eluting stent portfolio, supporting over 2 million global PCI procedures annually with USD 1.2 billion cardiovascular R&D investments, enhancing minimally invasive cardiac treatments across North America, including Canada.
- In May 2024, Canada stents market strengthened as Medtronic invested USD 2.1 billion in cardiovascular R&D, advancing structural heart technologies, coronary interventions, and AI-driven minimally invasive therapies across Canada and global interventional cardiology ecosystems.
Market Segmentation:
Canada Stents Market, By Product Type
-
- Coronary Stents
- Peripheral Stents
- Neurovascular Stents
- Urological Stents
- Others
Canada Stents Market, By Material Type
-
- Metallic Stents
- Polymer Stents
- Bioresorbable Stents
- Others
Canada Stents Market, By Technology
-
- Drug-Eluting Stents
- Bare-Metal Stents
- Bioresorbable Vascular Scaffolds
- Others
Canada Stents Market, By End User
-
- Hospitals
- Cardiac Care Centers
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Expert Views:
The Canada stent market is projected to experience robust future growth fueled by the growing prevalence of cardiovascular diseases, higher demand for minimally invasive techniques, and ongoing innovations in interventional cardiology technology in the country. The demand for drug eluting stents, bioabsorbable vascular scaffolds, and advanced cardiovascular intervention techniques will continue to fuel growth in the market.